Volumizing effects of a smooth, highly cohesive, viscous 20-mg/mL hyaluronic acid volumizing filler: prospective European study
Authors:
- the Juvéderm Voluma Study Investigators GroupTGthe Juvéderm Voluma Study Investigators Group
- Klaus HoffmannKHKlaus Hoffmann
Open Access
- 27 August 2009
- journal article
- clinical trial
- Published by Springer Nature in BMC Dermatology
- Vol. 9 (1) , 9
Abstract
Facial volume loss contributes significantly to facial aging. The 20-mg/mL hyaluronic acid (HA) formulation used in this study is a smooth, highly cohesive, viscous, fully reversible, volumizing filler indicated to restore facial volume. This first prospective study evaluated use in current aesthetic clinical practice.Keywords
This publication has 11 references indexed in Scilit:
- Hyaluronic Acid New Formulation: Experience in HIV-Associated Facial LipoatrophyDermatology, 2008
- Advances in Facial Rejuvenation: Botulinum Toxin Type A, Hyaluronic Acid Dermal Fillers, and Combination Therapies???-Consensus RecommendationsPlastic and Reconstructive Surgery, 2008
- Volumizing effect of a new hyaluronic acid sub‐dermal facial filler: A retrospective analysis based on 102 casesJournal of Cosmetic and Laser Therapy, 2008
- The science of hyaluronic acid dermal fillersJournal of Cosmetic and Laser Therapy, 2008
- Practical Use of Juv??derm: Early ExperiencePlastic and Reconstructive Surgery, 2007
- The Fat Compartments of the Face: Anatomy and Clinical Implications for Cosmetic SurgeryPlastic and Reconstructive Surgery, 2007
- Aging of the Midface Bony Elements: A Three-Dimensional Computed Tomographic StudyPlastic and Reconstructive Surgery, 2007
- Facial rejuvenation with botulinum neurotoxin: An anatomical and experiential perspectiveJournal of Cosmetic and Laser Therapy, 2007
- Full Scope of Effect of Facial Lipoatrophy: A Framework of Disease UnderstandingDermatologic Surgery, 2006
- Botulinum neurotoxin to treat chronic anal fissure: results of a randomized ‘Botox vs. Dysport’ controlled trialAlimentary Pharmacology & Therapeutics, 2004